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Abstract 
In neuropsychiatric research, animal studies that demonstrate causal effects of environmental 
manipulations relevant to human aetiological factors on emotional and cognitive behaviours 
relevant to human psychopathologies are valuable. Such valid animal models can be useful for 
improved understanding of aetio-pathophysiology and preclinical discovery and development of new 
treatments. In depression, specific uncontrollable stressful life events are major aetiological factors, 
and subsequent generalized increases in fearfulness, helplessness and fatigue are core 
psychopathology symptoms or features. In the present study we exposed adult male C57BL/6 mice 
to an environmental manipulation of 15-day psychosocial stress with loss of social control but with 
minimal physical wounding. One cohort of stressed and control mice was assessed in a novel 3-day 
test paradigm of motor activity, fear conditioning and 2-way avoid-escape behaviour on days 16-18, 
and a second cohort was assessed in a treadmill fatigue paradigm on days 19 and 29, followed by the 
3-day paradigm on days 30-32. All tests used a physical aversive stimulus, namely mild, brief 
electroshocks. The socially stressed mice displayed decreased motor activity, increased fear 
acquisition, decreased 2-way avoid-escape responding (increased helplessness) and increased 
fatigue. The socially stressed mice also displayed increased blood levels of the pro-inflammatory 
cytokine TNF and spleen hypertrophy, and adrenal hypertrophy without hyper-corticoidism. In a 
third cohort, psychosocial stress effects on brain gene expression were assessed using next 
generation sequencing. Gene expression was altered in pathways of inflammation and G-protein 
coupled receptors in prefrontal cortex and amygdala; in the latter, expression levels of a number of 
genes important in dopamine function were de-regulated including down-regulated Drd2, Adora2a 
and Darpp-32. Therefore, in a mouse model informed by depression aetiology and psychopathology, 
it was possible to demonstrate that chronic uncontrollable social stress leads to decreased motor 
activity and increased fear conditioning, helplessness and fatigue, each under physical aversive 
challenge, and to identify immune-inflammation and dopamine-function markers that were 
associated with these behavioural changes. This model can be applied to identify novel targets for 
treatment of specific psychopathologies such as generalized helplessness or fatigue, and to conduct 
preclinical screening of the compounds/biologics developed to act at these targets. 
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1. Introduction 
Depression has core symptoms of low mood, fatigue and anhedonia (ICD-10, 1994). The low mood 
core symptom involves the patient focusing on and emphasising aversive stimuli and events. The 
stressful life events that precede depression, e.g. psychosocial, financial, health, are often 
uncontrollable (Kendler et al., 2003; Kessler, 1997). It has been proposed that learned 
uncontrollability of one life event (specific helplessness) can become generalized to other life events 
regardless of their controllability, i.e. generalized helplessness (Abramson et al., 1989; Abramson et 
al., 1978; Beck et al., 1974; Diener et al., 2009; Maier and Seligman, 1976; Pryce et al., 2011). 
Generalized helplessness is proposed to comprise increased emotional responding to, reduced 
motivation to actively cope with, and reduced cognitive (response-outcome) expectancy to be able 
to cope with/control, aversive events; these states are clearly linked to low mood. Experimental 
evidence for these states include increased fear conditioning to stimuli that predict uncontrollable 
electroshock (Nissen et al., 2010), and increased helplessness during and after exposure to 
uncontrollable electroshock (Diener et al., 2009; Strigo et al., 2008), in depressed patients relative to 
healthy controls. The core symptom of fatigue is also complex and comprises experiencing physical 
and cognitive tasks as requiring extreme effort (Demyttenaere et al., 2005). The aetio-
pathophysiology of these important psychopathology symptoms and features is poorly understood. 
Understanding might be enhanced by the development and study of animal models that comprise 
(1) exposure to stressors that are relevant to human life events; (2) demonstrable effects of this 
stress on behaviour in tests that measure fear responding to aversive stimuli, helplessness when 
confronted with controllable aversive stimuli, and physical fatigue in an aversive environment. Such 
animal models would have aetiological and face validity for these depression psychopathologies 
(Cuthbert and Insel, 2013; Hyman, 2012; Markou et al., 2009).  
 There are currently two animal models of depression psychopathologies that are particularly 
widely used. In chronic unpredictable mild stress, rats or mice are exposed for 21-28 days to various 
physical and social stressors on an unpredictable schedule, and the major readouts are tests of 
reward sensitivity such as the sucrose preference test. Reward sensitivity is reduced, thereby 
providing a rodent model of stress-induced decreased interest (anhedonia) (Tye et al., 2013; Willner, 
1997). In chronic social defeat (CSD), mice are exposed to ten days of daily 10-minute attack by 
aggressive dominant mice, and otherwise there is continuous distal exposure to this psychosocial 
stressor. Stressed CSD mice display submissive behaviour but this fails to deter/control attacks by 
the dominant mice (Kudryavtseva et al., 1991). Bite wounds are common in the standard CSD 
protocol (Golden et al., 2011), somewhat impacting on its aetiological validity as an emotional 
psychosocial stressor. Readout tests of CSD effects have focussed on passive avoidance of the 
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aggressor mouse strain in a social proximity test (Krishnan et al., 2007; Savignac et al., 2011b); that 
is, on increased emotional reactivity to the specific learned uncontrollable social stimulus (Russo et 
al., 2012).  
We previously established a specific learned helplessness paradigm in mice using 2-way 
escape behaviour of mild, short electroshocks (Pryce et al., 2012). Mice exposed to electroshocks 
that can be terminated (controlled) by transfer from one side of an arena to the other readily learn 
this escape behaviour and maintain a high motivation (motor reactivity) across repeated 
electroshocks. Mice exposed to identical electroshocks in terms of duration, intensity and interval 
but now inescapable, i.e. no response-outcome contingency in terms of electroshock termination, 
exhibit progressively decreasing motivation (reduced motor reactivity) to control the aversive 
stimulus. When subsequently challenged with escapable shocks they exhibit few escape attempts 
and fail to learn from reinforced escape responses (Pryce et al., 2012). Using the same apparatus, 
one aim of the present study was to investigate whether CSD, which constitutes lack of social 
control, leads to generalized helplessness i.e. altered emotional, motivational and cognitive 
responding to another form of aversive stimulus, namely electroshock. Specifically, a 3-day test 
paradigm was used: motor activity test on day 1, contextual fear conditioning on day 2, and 2-way 
avoid-escape test on day 3. The motor activity test assessed whether CSD decreased activity and/or 
increased fear-freezing behaviour in a neutral environment; contextual fear conditioning assessed 
whether CSD increased fear-freezing reactivity to uncontrollable electroshock; the 2-way avoid-
escape test assessed whether CSD decreased motivation to control the aversive stimulus (motor 
reactivity to electroshock) and decreased cognitive expectancy to control the aversive stimulus 
(avoid-escape learning). Mice were tested sequentially in the different tests across days, so that for 
the later tests it was the effects of CSD on responses to (coping with) successive physical challenges 
that was under study. Whilst fatigue is a core symptom of depression, there does not appear to be 
an animal model for psychosocial stress induced increased fatigability. Using a treadmill combined 
with electroshock, fatigue induced by enforced running has been demonstrated in mice, and this 
method has been applied to study factors regulating fatigability, included proinflammatory cytokine 
administration, for example (Carmichael et al., 2006). Therefore, another aim of the present study 
was to investigate whether CSD induces increased fatigability under conditions of enforced treadmill 
running to avoid electroshock. The same mice were subsequently also investigated in the 3-day 
generalized helplessness paradigm. 
A final aim of this study was to investigate CSD effects on specific physiological and 
molecular genetic parameters that might contribute to the causation of any depression-relevant 
behavioural effects. One hypothesis of depression aetio-pathophysiology is psychosocial stress 
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activation of peripheral and central immune-inflammation, leading to oxidative stress and 
neurotoxic disruption of several neurotransmitters including serotonin, dopamine, glutamate and 
GABA (Dantzer et al., 2008; Felger and Miller, 2012). The proinflammatory cytokines of tumor 
necrosis factor (TNF) and interleukin-6 (IL-6) are increased in a majority of depression patients 
relative to matched controls (Dowlati et al., 2010; Maes, 2010). To render CSD aetiologically valid 
with respect to stress induced inflammation it was essential to introduce refinements to prevent the 
bite wounding that is frequent in the standard CSD protocol (Golden et al., 2011). The peripheral 
immune-inflammation markers of plasma TNF and IL-6 levels and spleen mass were measured. 
Markers of glucocorticoid function were also measured, namely adrenal gland mass and plasma and 
faecal corrticosterone levels. Whilst a number of studies have reported increased basal plasma 
cortisol levels in a subset of depressed patients relative to matched controls (Brown et al., 2004), 
there is also evidence for decreased plasma cortisol in depression and other stress-related disorders 
(Silverman and Sternberg, 2012). Another rationale for studying adrenal/corticosterone status is the 
evidence that stress can induce glucocorticoid resistance which in turn results in attenuation of its 
anti-inflammatory function (Rhen and Cidlowski, 2005; Silverman and Sternberg, 2012). Next 
generation sequencing and canonical pathway analysis were applied to conduct a hypothesis-free, 
transcriptome-level analysis of effects of CSD on gene expression in specific brain regions. The 
regions selected for study, ventral hippocampus, medial prefrontal cortex, and central and 
basolateral nuclei of amygdala, are fundamental to the neurocircuitries underlying the behaviours 
under study here (Amat et al., 2005; Maren et al., 2013; Moscarello and LeDoux, 2013) as well as the 
corresponding depression psychopathologies (Capuron et al., 2007; Disner et al., 2011; Mayberg, 
2003; Price and Drevets, 2010; Savitz et al., 2013; Sibille et al., 2009; Strigo et al., 2008).  
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2. Methods 
2.1. Animals and maintenance 
Breeding of C57BL/6J mice was conducted in-house. Male offspring were weaned at age 3 weeks 
and caged in groups of 2-3 littermates. The study was conducted with a total of 72 mice born to 26 
breeding pairs. Mice were aged 10-13 weeks and weighed 24.0-30.0 g at study onset. Male CD-1 
mice (Janvier, Saint-Berthevin, France) were aged 8 months, were ex-breeders, and caged singly at 
study onset. Mice were maintained on a reversed 12:12 h light-dark cycle (lights off 07:00-19:00 h) in 
an individually-ventilated caging system at 20-22 °C and 50-60% humidity. Cages were type 2L and 
contained woodchips, a sleep igloo and tissue bedding. Complete-pellet diet (Provimi, Kliba Ltd, 
Kaiseraugst, Switzerland) and water were available continuously. In the week prior to CSD, all 
C57BL/6J mice were handled and weighed on five days; body weights were used to assign mice to 
CSD and control (CON) groups such that mean weight per group was counterbalanced. The study 
was conducted under a permit (110/2009) for animal experimentation issued by the Veterinary 
Office, Zurich, Switzerland. All efforts were made to minimize the number of mice used and any 
unnecessary stress to those mice that were used, including refinement of the published protocol for 
CSD (Golden et al., 2011). 
 
2.2. Chronic social defeat 
A standard protocol for CSD (Golden et al., 2011) was used for the present study with refinements. 
Social defeat sessions were conducted under dim light on 15 consecutive days (versus 10 days in the 
standard protocol). On the day prior to day 1 of CSD, a CD-1 mouse demonstrated to be aggressive 
(Golden et al., 2011) was placed in one compartment of a cage (Indulab, Gams, Switzerland) 
containing a longitudinal divider made from transparent Plexiglas and perforated with multiple holes 
(∅ = 10 mm) for sensory interactions. To prevent bite wounds, a concern in the standard protocol 
(Golden et al., 2011), the lower incisors of these CD-1 mice were trimmed using rodent tooth-cutting 
forceps (Precision Surgical International, USA) under brief isoflurane anaesthesia; this was repeated 
at 3-day intervals across CSD. Daily CSD was conducted between 14:00-17:00 h. On day 1, each CSD 
C57BL/6J mouse was removed from its home cage, weighed and placed singly in the compartment of 
a CD-1 mouse. Behaviour was observed and the duration of each physical attack was timed; mice 
remained together until either a cumulative total of 60-sec physical attack had occurred or 10 min 
had elapsed (versus 10 min together regardless of attack time in the standard protocol). Also scored 
for each session were whether or not the CSD mouse fought back when attacked by the CD-1 mouse, 
and whether or not the CSD mouse displayed an upright submissive posture or submissive 
vocalisation.  When the CSD mouse displayed submissive behaviour, it was scored whether or not 
8 
 
the CD-1 mouse nonetheless attacked the CSD mouse. These behaviours were scored as did or did 
not occur per session, and the number of times per session that they occurred was not scored. The 
CSD mouse remained in the compartment in which it had been attacked and the CD-1 mouse was 
placed in the opposite compartment, allowing continuous olfactory, visual and auditory contact 
during the following 24 h. Because of behavioural observation and the timing of attack durations, 
CSD was conducted with only two cages at a time (versus 10 cages at a time in the standard protocol 
(Golden et al., 2011)). On day 2, the CSD x CD-1 mice pairings were rotated so that each CSD mouse 
was confronted with a novel CD-1 mouse and vice versa. The procedure was continued until day 15. 
Thereafter, each CSD mouse remained next to the same CD-1 mouse without any further attack 
sessions or rotations. Control (CON) mice remained in littermate pairs, the standard caging condition 
in our laboratory, and were handled and weighed daily (versus pairs of CON mice caged singly 
separated by dividers (Golden et al., 2011)). A pilot study comparing CON mice pairs maintained 
together or separated from each other by a divider demonstrated no effects in tests of motor 
activity, fear acquisition or two-way avoid-escape behaviour. 
 
2.3. Experimental design 
Three experiments were conducted, the designs of which are summarized in Figure 1. Experiment A 
(CON = 12, CSD = 13) investigated the effects of 15-day CSD on motor activity, contextual fear 
acquisition, two-way avoid-escape and hot-plate pain sensitivity at days 16-20, respectively. 
Physiological assessments were also conducted. Experiment B (CON = 10, CSD = 13) investigated the 
effects of 15-day CSD on treadmill fatigue at days 19 and 29, and on motor activity, contextual fear 
acquisition, two-way avoid-escape and hot-plate pain sensitivity at days 30-33, respectively. 
Experiment C (CON = 12, CSD = 12) investigated the effects of 15-day CSD on transcriptome 
expression in specific brain regions at day 17. 
 
     Figure 1 about here 
2.4. Motor activity, contextual fear acquisition and two-way avoid-escape behaviour 
Behavioural testing was conducted under dim lighting in a room adjacent to the mouse holding 
room, between 08:30-12:00 h except for the hot plate test (16:00-17:00 h). Motor activity, 
contextual fear acquisition and two-way avoid-escape testing were conducted on three consecutive 
days using a single system (Multi Conditioning System, TSE Systems GmbH, Bad-Homburg, 
Germany), details of which are given elsewhere (Pryce et al., 2012).  
 Motor activity test. The mouse was placed on the grid floor in the empty arena for 15 min, 
and distance moved (arbitrary units/min, a.u./min) and % time spent freezing were recorded 
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continuously using an infrared beam movement-detection system. Freezing episodes were defined 
and scored as no detectable movement for at least 2 sec. 
 Contextual fear acquisition. On the following day, the mouse was placed on the grid floor in 
the empty arena and exposed to 15 mild inescapable electroshocks of 0.15 mA x 3 sec delivered at 
inter-trial intervals (ITIs) of 50 sec. Mean reactivity to electroshock (a.u./min) and mean % time 
spent freezing during ITIs were calculated. 
Two-way avoid-escape test. On the following day, the mouse was placed on the grid floor in 
the arena which now contained a central divider with a gate, through which the mouse could 
transfer between identical left and right compartments. A first stage consisted of 10 trials each of 
12-sec tone (5 kHz, 85 dB, conditioned stimulus, CS) followed immediately by 0.15 mA x 3 sec 
inescapable electroshock, with ITIs of 50 sec. This tone-inescapable electroshock stage was included 
to ensure that all mice received equivalent tone aversive conditioning prior to two-way avoid-escape 
testing: otherwise, as observed in a pilot study, mice that are more active transfer frequently during 
early trials and terminate the CS before it becomes conditioned to the electroshock. (Data for this 
stage are not reported.) Directly thereafter, mice proceeded to the test, comprising 30 trials each of 
10-sec CS followed immediately by 0.15 mA x 5 sec-maximum escapable electroshock, with ITIs of 50 
sec. If the mouse did not transfer during tone + electroshock this was an avoid-escape failure; if the 
mouse transferred during the electroshock it was terminated immediately and this was an escape 
response; if the mouse transferred during the tone CS it was terminated immediately and the 
electroshock was omitted and this was an avoid response. The following measures were calculated 
for the two-way avoid-escape test: mean avoid-escape latency, mean % time freezing during tone 
and ITI, mean reactivity to electroshock, total avoid responses, total escape responses and total 
avoid-escape failures. 
2.5. Hot plate test 
To assess pain sensitivity, a hot plate test was conducted (Pryce et al., 2012). At 16:00-17:00 h the 
mouse was placed inside a chamber on a hot plate, and the latency (sec) from the onset of the test 
until the first occurrence of one of the following behaviours was scored: licking a forepaw, licking a 
hind paw, lifting a hind paw, jumping. The mouse was then removed immediately from the hot plate. 
The maximum test duration was 60 sec and 60 sec was the latency score given to mice that did not 
exhibit one of the target behaviours. 
2.6. Treadmill fatigue test 
The apparatus was a single lane treadmill (Panlab/Harvard Apparatus, Cornellà, Spain) inclined at 5° 
and with an electroshock grid at its lower end set at 0.15 mA. By running up-hill, mice could avoid 
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the grid, or if they had stopped running and travelled back onto the grid, escape from it. Total 
number and duration of electroshocks were scored automatically. A pilot experiment in non-
manipulated mice demonstrated that a treadmill speed of 20 cm/sec was a moderate running speed, 
and that 25 cm/sec was a fast running speed that mice could maintain for at least 20 min whilst 
receiving only a low number (5-15) and total duration (1-2 sec) of electroshocks. A training session 
consisted of 2 min at 0 cm/sec, 5 min at 15-20 cm/sec at 1 min increments, and 5 min at 20 cm/sec. 
A pre-test session consisted of 2 min at 0 cm/sec and 5 min at 20 cm/sec. Beginning immediately 
thereafter, a test session consisted of 20 min at 25 cm/sec. Measures were total electroshock 
duration at pre-test and, for the test session, running duration at 25 cm/sec (maximum 20 min) and 
total electroshock duration (maximum 10 sec) i.e. the session was terminated prior to 20 min if 
subjects accumulated a total of 10 sec electroshock at test. To ensure that differences in 
electroshock received could not carry over to influence behaviour in subsequent tests, mice that 
completed the 20 min test, i.e. received less than 10 sec electroshocks, were exposed to a further 
short session at high speed (35 cm/sec) until their total electroshock exposure reached 10 sec.  
2.7. Collection of faeces, blood, spleen, adrenal glands and brain 
In Expt A, fresh faecal boli were collected from the waste tray after behavioural testing on days 17, 
18 and 19 (mice placed in arena for 10 min without test on day 19) for corticosterone metabolite 
measurement, as a non-invasive marker of 24-hour plasma corticosterone levels on days 16 (motor 
activity test, without electroshock), 17 (fear acquisition test, with electroshock) and 18 (2-way avoid-
escape test, with electroshock), respectively. On day 20, mice were decapitated and trunk blood was 
collected in EDTA-coated tubes (Microvette 500 K3E, Sarstedt) and placed on ice. Bloods were 
centrifuged at 3000 rpm and 4° C for 10 min, plasma aliquots were transferred to cryotubes (Protein 
LoBind, Eppendorf) and stored at -80° C. Adrenal glands and spleen were removed, cleaned of fat 
and connective tissue and weighed. In Expt B, on day 33 mice were decapitated and adrenal glands 
and spleen were removed, cleaned of fat and connective tissue and weighed. In Expt C, on day 17 
mice were decapitated and the brain was removed, rinsed with ice-cold saline, frozen on dry ice and 
stored at -80° C. Adrenal glands and spleen were removed, cleaned of fat and connective tissue and 
weighed. 
2.8. Plasma cytokine measurement 
Plasma proinflammatory cytokines tumor necrosis factor (TNF) and interleukin-6 (IL-6) were 
measured using a multiplexed particle-based flow cytometric cytokine assay (Marques-Vidal et al., 
2011). The lower limit of detection for TNF and IL-6 was 0.5 pg/mL. 
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2.9. Corticosterone measurement 
Plasma corticosterone was measured using an EIA kit (AssayMax CORT ELISA kit; AssayPro, Saint 
Charles, MO, USA). Plasma was diluted 1:50 in kit diluent and heated at 90° C for 10 min for 
transcortin denaturation (Pryce et al., 2001). All further steps were performed according to the 
manufacturer’s protocol. Faecal samples were dried and powdered, 20-50 mg were extracted in 80% 
methanol. After centrifugation supernatants were stored at -20°C and transferred to Vienna. The 
faecal corticosterone metabolite 5α-pregnane-3ß,11ß,21-triol-20-one was measured using an in-
house EIA (Touma et al., 2003), to provide a non-invasive biomarker of blood corticosterone levels. 
2.10. Brain region-specific transcriptome expression 
Frozen brains from Expt C were sectioned coronally at 1 mm intervals using a stainless-steel brain 
matrix (model MMCS-1, Plastics One) and single-edge blades (model 10-100-063, Apollo Herkenrath, 
Solingen, Germany). Regions of interest were ventral hippocampus (vHIPP), amygdala (AMYG) and 
medial prefrontal cortex (mPFC; infralimbic cortex + ventral prelimbic cortex). These were 
microdissected bilaterally from corresponding sections using a brain punch (∅ = 1 mm, model 
57397, Stoelting Europe) and a mouse brain atlas (Franklin and Paxinos, 2008) (Fig. 6): mPFC (1 
biopsy/hemisphere) at bregma 2.1 to 1.2 ± 0.2 mm; AMYG (1 biopsy/hemisphere) at bregma -0.7 to -
1.7 ± 0.3 mm; vHIPP (2 biopsies/hemisphere) at bregma -2.8 to -3.9 ± 0.3 mm. Tissue mass was 0.6-
0.8 mg per biopsy. All microdissection steps were conducted at -18 °C. Brain biopsies were stored in 
1.5 ml DNA LoBind polypropylene tubes (Eppendorf, model 0030 108.051) at -80 °C. 
 For RNA isolation, samples were homogenised in 400 µl 1%-ß-mercaptoethanol-RLT-buffer, 
and total RNA was isolated from 200 µl homogenate using the RNeasy Micro Kit (Qiagen, Hilden, 
Germany) according to the manufacturer’s instructions. The high quality of the RNA was determined 
using the RNA 6000 Nano kit and a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, USA). 
Preparation of the mRNA sequencing library, separately for each sample (CSD N = 12, CON N = 12, 
i.e. without pooling) was conducted using 200 ng of total RNA in the TrueSeq RNA Sample 
Preparation Kit v2-Set B (RS-122-2002, Illumina Inc, San Diego, USA); this yielded fragments of an 
average size of 275 bp including the adapters with their library-specific indices supplied by the 
manufacturer. Concentration of the libraries was normalised and eight libraries were multiplexed 
and clustered on the cBot Instrument (Illumina Inc) using the TruSeq SR Cluster Kit v3 - cBot – HS 
(GD-401-3001, Illumina Inc). Sequencing was performed with single reads of 52 bp using the TruSeq 
SBS Kit HS - v3 (FC-401-3002, Illumina Inc) on an Illumina HiSeq2000 instrument. Read alignment of 
the RNA-seq dataset was performed using STAR aligner software (Dobin et al., 2013). Gene 
expression analysis was conducted using Cufflinks software with differential expression of genes in 
CSD (N = 12) versus CON (N = 12) mice identified using the Cuffdiff 2 test (Trapnell et al., 2013). 
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Briefly, the Cuffdiff 2 test assesses between-group log-fold change in gene expression against the 
null hypothesis of no change whilst controlling for false discovery rate (FDR) using the Benjamini-
Hochberg correction for multiple-testing. The criteria used to identify differential gene expression in 
CSD relative to CON mice were mean reads per kilo base per million (RPKM) > 5, mean fold change > 
1.4, and q < 0.05. Within and between the three regions of interest, those genes that met these 
criteria for significantly increased or decreased expression in CSD versus CON mice were investigated 
in terms of canonical pathways and upstream regulator networks, using Ingenuity Pathway Analysis 
(IPA, Ingenuity Systems, Redwood City, USA). The undetectable/low level of expression of globin 
genes (Hbb) demonstrated that brain tissue contamination with blood cells was negligible. 
 
2.11. Statistical analysis 
Statistical analysis of CSD effects on behaviour and physiology was conducted using SPSS (version 20, 
SPSS Inc., Chicago IL, USA). In most cases a t-test was conducted. Analysis of variance (ANOVA) was 
conducted in cases of a between-subject factor of group (CSD, CON) and a within-subject factor of 
CSD day block (e.g. body weights). ANOVA post hoc testing was conducted using the Bonferroni 
correction for multiple comparisons. Statistical significance was set at p ≤ 0.05. Where an estimate 
of variance is given this is the standard deviation (SD). In the case of behavioural and physiological 
measures, for CSD and CON mice separately, correlations were run to determine if any of these 
parameters varied together; consistent evidence that certain mice displayed high CSD effects and 
others low CSD effects would point towards relative susceptibility and resilience, respectively. As a 
partial control for multiple testing of correlations, statistical significance was set at p ≤ 0.01.    
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3. Results 
3.1. Chronic social defeat 
In the daily social defeat sessions the mean duration of attacks received on days 1-15 by C57BL/6 
CSD mice in experiments A, B and C was, respectively, 47 ± 3, 44 ± 4 and 46 ± 5 sec (mean ± SD). 
Table 1 summarises the outcome of CSD sessions in three 5-day blocks. Attacks occurred in each CSD 
session and the average total duration of attacks decreased to a small extent from CSD days 1-5 to 
11-15. A minority of CSD mice were observed to fight back when being attacked by a CD-1 aggressor 
mouse, and this was largely restricted to CSD days 1-5. Thereafter, all CSD mice were observed to 
exhibit submissive body postures and emit submissive vocalisations during the majority of social 
defeat sessions. Furthermore, all CD-1 aggressor mice were observed to attack despite these 
submissive signals. Therefore, CSD mice experienced repeated absence of control in an aversive 
social situation. CSD mice were controlled for wounding immediately after each session. Because of 
regular trimming of the incisor teeth of CD-1 mice, wounding was rare: per experiment, there were 
1-2 surface wounds (skin abrasions) in 2-4 mice, and these were more common on CSD days 6-10 
and 11-15; importantly, deep bite wounds (skin penetration) did not occur. 
     Table 1 about here     
     Figure 2 about here 
3.2. Motor activity, fear acquisition, helplessness and fatigue 
In Expt A, in the motor activity test (MA, day 16), CSD mice exhibited decreased activity relative to 
CON mice (arbitrary units/min: CSD 3907 ± 1535, CON 5806 ± 2113, t(23) = 2.59, p < 0.02). In the 
same test, CSD and CON mice spent a similar, low % of time freezing (p = 0.62, Fig. 2A). In the fear 
acquisition test (FA, day 17), CSD mice exhibited increased mean % time fear freezing relative to 
CON mice (t(23) = -4.41, p < 0.0005, Fig 2A). There was no effect of CSD on reactivity to electroshock 
(p = 0.14, Fig. 2B). In the 2-way avoid-escape test (E-A, day 18), CSD mice exhibited a greater mean 
latency to avoid-escape (t(23) = -3.00, p < 0.006, Fig. 2C). CSD mice did not make more avoid-escape 
failures (CSD 14.2 ± 10.1, CON 8.8 ± 5.1, p = 0.11), but they did make less avoid responses than CON 
mice (t(23) = 2.70, p < 0.01, Fig. 2D). The CSD mice also exhibited increased mean % time fear freezing, 
both during tones (t(23) = -4.18, p < 0.0005, Fig. 2E) and 50-sec intervals between successive tone-
electroshock pairings (t(23) = -4.64, p < 0.0005, Fig. 2E). Therefore, during tone CSs, CSD mice 
displayed more freezing and less avoids. There was no CSD effect on reactivity to electroshock (p = 
0.31, Fig. 2F). In the hot plate test (day 19), there was no effect of CSD on latency to display a pain 
response: CSD 18.0 ± 11.5 sec, CON 22.5 ± 11.8 sec (p = 0.35). Within CSD mice specifically, % time 
freezing during the motor activity test (Fig. 2A) predicted % time freezing during tones (r=0.80, 
p<0.0009) and ITIs (r=0.76, p<0.002) in the avoid-escape test (Fig. 2E). Furthermore, the number of 
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avoid responses (Fig. 2D) was inversely correlated with the mean duration of attacks received during 
CSD sessions (Table 1) (r=-0.72, p<0.006). 
 
     Figure 3 about here 
 
 In Expt B, at treadmill training (TTr, day 18), there was no CSD effect on total electroshock 
time (CSD 11.9 ± 10.7 sec, CON 7.3 ± 2.5 sec, p = 0.25). On day 19, during the 5 min treadmill pre-
test at 20 cm/sec, there was also no CSD effect on total electroshock time (p = 0.11, Fig. 3A). 
However, two outlier CSD mice received 60 sec of total electroshock during this pre-test and were 
removed from all subsequent testing for welfare reasons. At test (TTe), CSD mice ran less than CON 
mice as indicated by the decreased running time achieved before delivery of a total 10 sec 
electroshocks (t(19) = 4.40, p < 0.0005, Fig. 3B). Nine of 11 CSD mice received the maximum 10-sec 
electroshocks compared with zero of 10 CON mice. The mean duration of each electroshock did not 
differ between the groups (CSD 0.23 ± 0.11 sec, CON 0.20 ± 0.08 sec, p = 0.58), indicating that CSD 
and CON mice required a similar time to escape from the electrified grid each time they ceased 
running and came into contact with it. On day 29, during the 5 min pre-test at 20 cm/sec, there was 
a CSD effect on total electroshock time (t(19) = -2.23, p < 0.04, Fig. 3C). At test, running time achieved 
was decreased in CSD relative to CON mice (t(19) = 5.42, p < 0.0005, Fig. 3D). All 11 CSD mice received 
the maximum 10 sec electroshocks versus only one of 10 CON mice. The mean duration per 
electroshock was greater in CSD (0.26 ± 0.10 sec) than CON mice (0.17 ± 0.05 sec, p < 0.01), 
indicating that CSD mice were now slower to escape from the electrified grid each time they ceased 
running and came into contact with it. Within CSD mice specifically, test running time achieved on 
day 29 was correlated with test running time achieved on day 19 (r=0.73, p<0.01).  
 
     Figure 4 about here 
 
 In the same mice, in the motor activity test (day 30), there was no CSD effect on activity (CSD 
3429 ± 1722, CON 4682 ± 1998 a.u./min, p = 0.14) or % time freezing (p = 0.11, Fig. 4A). In the fear 
acquisition test (day 31), as for Expt A (Fig. 2A), CSD mice exhibited increased mean % time fear 
freezing relative to CON mice (t(19) = -3.55, p < 0.002, Fig. 4A). In contrast to Expt A (Fig. 2B), CSD 
mice exhibited decreased reactivity to electroshock compared to CON mice (t(19) = 3.82, p < 0.001, 
Fig. 4B). In the 2-way avoid-escape test (day 32), CSD mice displayed a greater mean latency to 
avoid-escape than CON mice (t(19) = -2.16, p < 0.04, Fig. 4C). The CSD mice made more avoid-escape 
failures (t(19) = -2.66, p < 0.02, Fig. 4D) and less escapes (CSD 9.6 ± 7.0, CON 17.2 ± 6.9, t(19) = 2.49, p < 
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0.02) than CON mice, while there was no difference in avoids (CSD 5.6 ± 5.5, CON 7.9 ± 5.0, p = 
0.34). There was no CSD effect on % time spent freezing during tones (p = 0.83, Fig. 4E) or intervals 
between successive tone + electroshock pairings (p = 0.67, Fig. 4E). CSD mice exhibited decreased 
reactivity to electroshock (t(19) = 3.13, p < 0.006, Fig. 4F). Within CSD mice specifically, % time 
freezing during the motor activity test (Fig. 4A) was associated with % time freezing in the avoid-
escape test, both during tones (r=0.83, p<0.002) and ITIs (r=0.73, p<0.01) (Fig. 4E). Also within CSD 
mice specifically, % time spent freezing during tones (Fig. 4E) was correlated with avoid-escape 
latency (r=0.91, p<0.0005, Fig. 4C) and number of avoid-escape failures (r=0.76, p<0.007, Fig. 4D). 
Therefore, in experiments A and B, CSD mice exhibited evidence of helplessness in the 2-way avoid-
escape test but the specific behavioural effects differed: In Expt A (day 18) the deficits were 
increased avoid-escape latency due to impaired avoidance combined with increased freezing and no 
effect on electroshock reactivity. In Expt B (day 32, after treadmill testing) the deficits were 
increased avoid-escape latency due to increased avoid-escape failure, no overall effect in freezing, 
and decreased electroshock reactivity. In the hot plate test (day 33), there was no effect of CSD on 
latency to display a pain response: CSD 20.0 ± 9.4 sec, CON 23.6 ± 11.3 sec (p = 0.46). In Expt B, there 
were no significant correlations between measures of treadmill behaviour and measures of avoid-
escape behaviour, and also no significant correlation between any of these outcome measures and 
the mean duration of attacks received in CSD mice. 
     Figure 5 about here 
3.3. Physiological status  
In experiments A, B and C there was no effect of CSD on mean absolute body weight (BW) per 5-day 
block (e.g. Expt A, group x day-block interaction, p = 0.13; Fig. 5A). However, mean day-to-day BW 
delta (∆BW) per 5-day block was increased in CSD relative to CON mice, and similarly across the 
three experiments: for example, in Expt A there was a main effect of group (F(1, 27) = 9.18, p < 
0.005) and post hoc comparisons per 5-day block indicated that mean ∆BW was greater in CSD than 
CON mice at days 2 to 6 and 7 to 11 (Fig. 5B).  
 In Expt A, at day 20, relative to CON mice, CSD mice had increased basal plasma 
concentrations of TNF (t(23) = -2.95, p < 0.007, Fig. 5C) and IL-6 (non-normal distribution, Mann-
Whitney U = 36, N = (12, 13), p < 0.02, Fig. 5D). They also exhibited increased spleen weight, both 
absolute (t(23) = -3.90, p < 0.001) and relative to BW (t(23) = -3.38, p < 0.003, Fig. 5E). Significant spleen 
hypertrophy in CSD mice was also observed in Expt B (day 34) and Expt C (day 17) (data not shown). 
Total adrenal gland weight was increased in CSD relative to CON mice, both absolute (t(23) = -2.30, p < 
0.03) and relative to BW (t(23) = -2.13, p < 0.04, Fig. 5F). Significant adrenal gland hypertrophy was 
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also observed in Expts B and C (data not shown). There was no effect of CSD on basal plasma 
corticosterone at day 20 (p = 0.60, Fig. 5G). For faecal corticosterone metabolite (Fig. 5H) there was 
a main effect of group (F(1, 27) = 4.52, p < 0.05) and a main effect of day (F(2, 54) = 6.60, p < 0.003). 
A posteriori analysis of CON and CSD mice separately demonstrated a significant day effect in CON 
mice (F(1, 26) = 4.63, p < 0.02) and not in CSD mice (p = 0.13); in CON mice specifically, faecal 
corticosterone metabolite was increased on days 18 and 19 (electroshocks received on previous day) 
relative to day 17 (no electroshocks on previous day) (p < 0.02, Fig. 5H). In CSD and CON mice 
analysed separately, there were no significant correlations between physiological measures and 
measures of fear conditioning, avoid-escape behaviour or treadmill behaviour. In CSD mice, there 
was no significant correlation between physiological measures and the mean duration of attacks 
received.         
     Figure 6 about here 
     Table 2 about here 
3.4. Gene expression 
In Expt C (no behavioural testing), brains were collected at day 17 and differential gene expression 
was investigated for ventral hippocampus (vHIPP), amygdala (AMYG) and medial prefrontal cortex 
(mPFC) using next generation sequencing in 12 replicates per group (Fig. 6). The complete sets of 
genes that satisfied the expression criteria and were significantly up-regulated (↑) or down-
regulated (↓) in CSD relative to CON mice are listed according to region(s) in supplementary Tables 
S1 and S2, respectively. In vHIPP, CSD mice exhibited increased and decreased expression of 21 and 
33 genes, respectively (Fig. 6, Tables S1, S2). One of the up-regulated genes was Tnfrsf25, a member 
of the TNF-receptor superfamily; one of the down-regulated genes was Cadps2, a member of the 
calcium-dependent activator of secretion protein family that regulate the exocytosis of synaptic and 
dense-core vesicles in neurons. Using Ingenuity pathway analysis (IPA), there was no canonical 
pathway that was associated with more than one of these genes. However, upstream IPA identified 
the proinflammatory cytokines TNF, IL-6 and IL-3 as significant regulators of these genes. In AMYG, 
CSD mice exhibited increased and decreased expression of 22 and 48 genes, respectively (Fig. 6, 
Tables S1, S2). In terms of canonical pathways, these genes were primarily associated with “T cell 
receptor signalling” (4 genes: Cd4 (↓), Jun (↑), Ptprc (↑), Shb (↓)), “G-protein coupled receptor 
signalling” (5 down-regulated (↓) genes: Drd2, Adora2a, Chrm3, Htr2a, Pde10e), and “C-C chemokine 
receptor type 5 (CCR5) signalling in macrophages” (3 genes: Cd4 (↓), Jun (↑), Gng7 (↓)). A number of 
the genes exhibiting altered expression in AMYG of CSD relative to CON mice encode proteins that 
bind dopamine and are involved in either mediating or regulating dopamine neurotransmission 
(Table 1). One of the genes, Slc29a4 (↑), encodes a dopamine and serotonin reuptake protein, and 
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expression of the serotonin receptor Htr2a (↓) was also responsive to CSD. Furthermore, IPA 
upstream analysis identified dopamine as a transcription regulator for several genes exhibiting 
altered expression in AMYG of CSD mice (Table 2). In mPFC, CSD mice exhibited increased and 
decreased expression of 6 and 14 genes, respectively (Fig. 6, Tables S1, S2). As for AMYG, the 
canonical pathways primarily associated with these genes had immune-inflammatory function, 
namely “IL-12 signalling and production in macrophages”, and “production of nitric oxide and 
reactive oxygen species in macrophages”. The same three genes enriched both pathways, namely 
Apod (↓), Fos (↑) and Prkcd (↑).  
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4. Discussion 
The overall aim of the present study was to investigate effects of chronic exposure to a psychosocial 
stressor on behavioural responses to physical stress and associated changes in physiology and brain 
gene expression, in adult male mice. The study design was informed by the generalized helplessness 
hypothesis of depression, which proposes that exposure to a specific aversive life event (stressor) 
that is of high emotional significance and uncontrollable leads to altered responding to all aversive 
life events, including increased negative emotionality, decreased motivation to actively cope 
with/control the adversity, and reduced cognitive expectancy to cope with/control the adversity 
(Abramson et al., 1989; Abramson et al., 1978; Beck et al., 1974; Diener et al., 2009; Kendler et al., 
2003; Kessler, 1997; Maier and Seligman, 1976; Pryce et al., 2011). Although it is one of the few 
succinct hypotheses of depression onset-maintenance, research into the neurobiology that might 
underlie generalized helplessness has been scant, and relevant animal models would make an 
important contribution to this. Here it was demonstrated that mice exposed to chronic social defeat 
without physical wounding developed sustained states of decreased motor activity, increased 
acquisition of fear, decreased active responding to an aversive conditioned stimulus or to the 
unconditioned stimulus, and increased fatigability, in response to a physical stressor in the form of 
mild electroshock. These findings are consistent with a mouse model of generalized helplessness. 
The behavioural effects co-occurred with peripheral and central indices of immune-inflammatory 
activation and, in the amygdala, changes in expression of genes important for dopamine function. 
Although correlational, this physiological and genetic evidence could be important to identifying the 
systems underlying the observed behavioural effects and, furthermore, generalized helplessness in 
human depression.     
A modified version of the most widely-used protocol (Golden et al., 2011) for chronic social 
defeat was used in this study. As stated in the standard protocol, bite wounding is common and we 
also observed this in pilot studies. The refinements of regular trimming of the incisor teeth of CD-1 
mice and restricting of attacks to 60 sec/day resulted in a complete absence of skin penetration bite 
wounds; the majority of mice had no physical wounds and a minority received occasional surface 
abrasions. Therefore, in the present study CSD was primarily an emotional social stressor. The 
insightful first report of CSD describes that the characteristic displays of submissive behaviour by 
CSD mice were ineffective in controlling attacks by the aggressor mice (Kudryavtseva et al., 1991), 
and the same was observed here (see also Savignac et al., 2011b). That is, CSD mice experience 
repeated encounters with uncontrollable dominant mice and otherwise continuous exposure to the 
sensory stimuli associated with these social stressors. Furthermore, a different dominant mouse was 
encountered each day, thereby increasing the unpredictability of the stressor. Because attack 
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duration was limited to 1 min/day, in contrast to the possible 10 min/day in the standard protocol, 
the chronicity of the social stressor was increased from 10 to 15 days.The control mice were 
maintained in our standard caging condition of littermate pairs rather than singly, so that single 
caging must be considered as a component of the CSD procedure in our experimental design. As 
stated in the Methods, a pilot study comparing CON mice pairs maintained together or separated 
from each other by a divider demonstrated no effects in tests of motor activity, fear acquisition or 
two-way avoid-escape behaviour. 
With regards to behavioural effects, the 3-day paradigm was designed to allow for the 
assessment of CSD effects on emotional, motivational and cognitive responses to a different 
stressor, namely electroshock, presented in different settings. In Expt A, CSD resulted in decreased 
motor activity but not increased fear freezing in a neutral context. On the following day, CSD mice 
acquired increased fear freezing to this same context when exposed to mild inescapable 
electroshocks. In the two-way avoid-escape test, CSD mice exhibited a deficit in the active 
responding to the CS that was reinforced by CS termination and electroshock omission. Given that 
this deficit co-occurred with increased fear freezing, it could reflect either increased emotional 
reactivity or decreased response-outcome cognitive expectancy, or both processes. These mice did 
not exhibit decreased electroshock reactivity, indicating intact motivation to react to an aversive 
stimulus. In Expt B, the same test battery was conducted after treadmill testing and 2 weeks later 
than in Expt A. There was no CSD effect on motor activity in a neutral context; this contrast to Expt A 
was due primarily to the reduced activity of CON mice in Expt B versus A. CSD mice acquired 
increased fear freezing to this context when exposed to mild inescapable electroshocks (as in Expt 
A), although this co-occurred with decreased electroshock reactivity (not the case in Expt A); these 
findings are consistent with increased aversive emotionality and decreased motivation to react to an 
aversive stimulus, respectively. In the two-way avoid-escape test, CSD mice were deficient in active 
responding to the escapable electroshock, as demonstrated by increased avoid-escape failures and 
decreased electroshock reactivity. These deficits could reflect decreased motivation to react to or 
decreased expectancy to control an aversive stimulus, or both; that they were not accompanied by 
increased freezing suggests that fear was not increased. This behavioural profile of CSD mice in Expt 
B was remarkably similar to that of mice exposed repeatedly to inescapable electroshock and then 
tested with escapable electroshock; such mice also exhibit high escape failure i.e. specific learned 
helplessness, low electroshock reactivity, and no increase in fear freezing (Pryce et al., 2012). 
Increased stress-induced analgesia in CSD mice might have contributed to the effects observed, but 
two findings indicate that this was unlikely: CSD mice exhibited decreased electroshock reactivity 
together with increased freezing in the contextual fear test in Expt B; there was no effect of CSD in 
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the hot plate test in Expts A or B. Comparing Expts A and B, the increased deficit in actively 
responding to electroshock demonstrated by CSD mice in Expt B could be due to carryover effects of 
an interaction between CSD and treadmill testing (see below), or to the additional 14 days between 
CSD and two-way avoid-escape testing; further experiments will be required to investigate this. The 
current findings demonstrate that mouse CSD induces altered emotional, motivational and cognitive 
responding to mild electroshock stimuli in accordance with the hypothesis of generalized learned 
helplessness. The exact protocol to be used in future studies would depend on the specific aims: a 
focus on generalized increased emotionality to aversive stimuli should combine CSD and fear 
conditioning; focus on generalized impaired cognitive control should combine CSD and two-way 
avoid-escape; and focus on generalized decreased motivation to react to aversive stimuli should 
combine CSD plus an additional challenge (e.g. treadmill) followed by two-way avoid-escape. Each of 
these models would be relevant to a specific depression psychopathology and to the study of its 
underlying aetio-pathophysiology. Additional psychopathologies will also need to be addressed in 
future experiments. Important among these will be whether CSD leads to deficits in extinction of 
fear memory, as shown for other stressors (Zhang and Rosenkranz, 2013), which would be relevant 
to the deficient cognitive flexibility that is a common symptom of depression (Clark et al., 2009). 
Furthermore, CSD effects on reward processing will need to be investigated in future studies, to 
examine whether the depression-relevant increase in punishment reactivity demonstrated here co-
occurs with a decrease in reward sensitivity, relevant to the core depression symptom of reduced 
interest and pleasure. The sucrose preference test (Willner, 1997), intra-cranial self-stimulation 
(Slattery et al., 2007), and operant tests such as sucrose pellet reinforcement on a progressive ratio 
schedule (Ineichen et al., 2012), are examples of relevant readout tests.       
To our knowledge treadmill testing has not been applied previously in an animal model of 
depression. This is surprising given the use of rodent treadmill running as a readout for fatigability in 
exercise physiology e.g. (Massett and Berk, 2005) and in response to inflammation e.g. (Carmichael 
et al., 2006), and also given that fatigue is a core depression symptom (ICD-10, 1994). Relative to 
CON mice, which were able to complete the tests conducted on days 19 and 29, CSD mice displayed 
a running deficit in both tests. At day 19, CSD mice exhibited running comparable to that of CON 
mice in the 20 cm/sec pre-test, with the exception of two CSD mice that were unable to run 
consistently even at this speed and were removed from further study for welfare reasons. In the test 
at 25 cm/sec, most CSD mice could not maintain the required running speed; two sub-groups 
formed in terms of mice that were or were not able to run for at least 600 sec. At day 29, a sub-
group of CSD mice were already unable to run consistently at the pre-test and 9 of 11 CSD mice were 
not able to run for at least 600 sec at test. The CSD running deficit could be due to increased motor 
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fatigability, increased emotionality, decreased motivation to respond actively to an aversive 
stimulus, decreased response-outcome expectancy, or a combination of these factors. Given that 
human fatigue in depression comprises components of physical tiredness, motor retardation, 
deficient motivation,  emotional fatigue and cognitive fatigue (Demyttenaere et al., 2005), then strict 
differentiation between these components is probably artificial. The CSD-treadmill fatigue model can 
be applied to increase understanding of fatigue neurobiology, in terms of its separate components 
and their interaction. 
The present findings add to those reported previously for CSD. CSD has been reported to 
increase expression of fear freezing to context and CS (Yu et al., 2011). As noted in the Introduction, 
for CSD behavioural effects the major focus to-date has been on passive avoidance by CSD mice of 
mice from the dominant aggressor CD-1 strain in a social proximity test (Berton et al., 2006; Haque 
et al., 2012; Krishnan et al., 2007; Savignac et al., 2011a). In terms of helplessness theory, this effect 
constitutes increased emotional reactivity to the specific stimulus that induced the CSD (Russo et al., 
2012). In some studies, passive avoidance of CD-1 mice has been reported to occur in about 50% of 
CSD mice with the other 50% not avoiding the dominant aggressor strain (Krishnan et al., 2007). The 
mice that developed passive avoidance also developed a reduction in sucrose preference, whereas 
CSD mice that did not develop social passive avoidance also exhibited normal sucrose preference 
(Krishnan et al., 2007). In the present study, significant effects of CSD in terms of increased fear 
acquisition, decreased avoidance, increased avoid-escape failure, decreased electroshock reactivity 
and increased fatigue, were obtained with sample sizes of 10-13 mice without division into sub-
groups. However, as described above, two sub-groups were apparent in some stages of treadmill 
fatigue testing. It was not the case that CSD mice which exhibited relatively large effects in terms of 
treadmill fatigue also exhibited relatively high fear freezing and avoid-escape failures; that is, there 
was no consistent evidence for relatively susceptible versus resilient mice. Although there was not a 
significant CSD effect on fear freezing in the neutral motor activity test, this parameter did predict 
fear freezing during the avoid-escape test; as such fear freezing in the neutral environment will 
provide a valuable marker for balanced allocation of CSD mice to drug treatment groups in future 
pharmacological studies with this model.    
In terms of physiological effects, CSD did not impact on absolute body weight. Previous 
studies report that CSD increased (Bartolomucci et al., 2009), decreased (Kudryavtseva et al., 1991) 
or had no effect on (Savignac et al., 2011a) absolute body weight. Decreased and increased body 
weight are both facultative depression symptoms (ICD-10, 1994). In the present study CSD did 
increase day-to-day body weight variability; high variability is associated with negative affect and 
low self-esteem in humans (Foreyt et al., 1995; Serdar et al., 2011). A major rationale for refining the 
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CSD protocol to eliminate bite wounding was to render the current model compatible with the study 
of the immune-inflammation hypothesis of depression. Accordingly, it is interesting that plasma 
levels of the pro-inflammatory cytokine TNF were increased in CSD mice, as was IL-6 in a sub-group 
of these mice. A CSD study in BALB/c CSD mice and C57BL/6 aggressor mice also reported increased 
plasma levels of TNF and proinflammatory interleukins; although the standard CSD protocol was 
used there were no correlations between cytokine level and number of bite wounds received 
(Savignac et al., 2011a). In healthy humans, acute psychosocial stress causes increased blood levels 
of pro-inflammatory cytokines (Bierhaus et al., 2003) and blood levels of TNF and IL-6 are increased 
in depression (Dowlati et al., 2010). In addition, the spleens of CSD mice were hypertrophic, 
consistent with invasion and expansion of activated immune cells. Studies using the standard CSD 
protocol report either spleen hypertrophy (Bartolomucci et al., 2004) or normal spleen size (Savignac 
et al., 2011a) in CSD mice. Adrenal glands were also hypertrophic in CSD mice, as observed in mice 
exposed to chronic subordinate colony housing (Reber et al., 2007). Despite adrenal hypertrophy, 
basal plasma CORT levels in blood samples collected at the termination of Expt A were not increased 
in CSD mice. Previous CSD studies report that basal plasma CORT is increased (Perez-Tejada et al., 
2013) or unchanged (Krishnan et al., 2007). Furthermore, in faecal boli collected across the 3-day 
paradigm in Expt A, CORT metabolite was increased on post-stress days in CON but not in CSD mice. 
The combination of adrenal hypertrophy, no increase in basal CORT and evidence for decreased 
CORT stress-reactivity, is consistent with adrenal insufficiency in terms of response to ACTH 
challenge, as reported for chronic subordinate colony housing (Reber et al., 2007). Therefore, CSD 
mice exhibited signs of immune-inflammatory activation combined with an adrenal insufficiency that 
would dampen anti-inflammatory corticoid activity; this would predispose them to stress-induced 
activation of immune-inflammatory pathways and the pathological effects thereof (Rhen and 
Cidlowski, 2005; Silverman and Sternberg, 2012). It was not the case that CSD mice which exhibited 
relatively large effects in terms of inflammatory or adrenal measures also exhibited relatively large 
behavioural effects of CSD; that is, there was no consistent evidence for relatively susceptible versus 
resilient mice. 
Given the observed behavioural effects of CSD, specific brain regions important in the 
circuitries of fear conditioning (AMYG, vHIPP (Maren et al., 2013)), avoid-escape learning (AMYG, 
mPFC (Moscarello and LeDoux, 2013)), specific learned helplessness (mPFC (Amat et al., 2005; Pryce 
et al., 2011)) and fatigue (DeLuca et al., 2009), were investigated in terms of CSD effects on 
transcriptome-level gene expression, with brains collected at day 17. Importantly, these same 
regions exhibit altered structure-function-molecular genetic changes in depression e.g. (Disner et al., 
2011; Mayberg, 2003; Price and Drevets, 2010; Savitz et al., 2013; Sibille et al., 2009). The 
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experiment was conducted using next-generation sequencing, and genes that were expressed above 
a threshold level and were significantly altered in their expression in CSD versus CON mice were 
subjected to pathway analysis to identify the processes and pathways with which they are most 
commonly associated and their upstream regulators. In vHIPP, for 11 of the 54 genes with altered 
expression in CSD mice, the pro-inflammatory cytokines TNF, IL-6 and IL-3 are major upstream 
regulators of expression, and the former two were increased in the plasma of CSD mice. The up-
regulated genes included the TNF-receptor superfamily gene Tnfrsf25, the protein encoded by which 
stimulates NF-κβ and cell apoptosis. In AMYG, CSD led to de-regulation of 70 genes (48 ↓ and 22 ↑). 
Two of the three canonical pathways most enriched by these genes were “T cell receptor signalling” 
and “CCR5 signalling in macrophages”, suggesting that CSD initiated changes in immune-
inflammation transcription processes in this region. In the former pathway, Ptprc, an essential 
regulator of cytokine signalling, was up-regulated in CSD mice; in the latter pathway, shb, an 
inhibitory regulator of T cell receptor, was down-regulated in CSD mice, consistent with disinhibition 
of T cell signalling (Gustafsson et al., 2011). Another down-regulated gene in the CCR5 pathway was 
Gng7: Gng7 is coupled to the dopamine (DA) 1 receptor and mice deficient in Gng7 exhibit down-
regulation of DA 2 receptor (D2R) (Sasaki et al., 2013). In mPFC, CSD led to de-regulation of 20 genes 
(14 ↓ and 6 ↑). The canonical pathways most enriched by these genes were immune-inflammatory, 
namely “IL-12 signalling and production of macrophages”, and “production of nitric oxide and 
reactive oxygen species in macrophages”. One of the up-regulated genes was Prkcd: Prkcd has been 
identified as a major mediator of TNF-induced degeneration of DA neurons (Gordon et al., 2012). 
Several recent human studies report increased expression of immune-inflammation genes in 
depressed relative to healthy-control probands. These include a genome-wide expression study of 
peripheral blood mononuclear cells that identified increased TNF expression in depression (Savitz et 
al., 2013), and a post mortem brain tissue microarray study reporting increased expression of pro-
inflammatory and anti-inflammatory cytokine pathway genes in the mPFC in depression (Shelton et 
al., 2011). Specific evidence for increased density or activation of microglia was not obtained in the 
present study. For genes expressed by microglia, e.g. toll-like receptors, expression levels were 
below the threshold level (>5 RPKM) for reliable quantification. Indeed, previous studies that have 
demonstrated that CSD-like manipulations do activate microglia have used whole-brain cell sorting 
and flow cytometry to isolate microglia (e.g. Wohleb et al., 2011). This methodology will need to be 
applied to the current model in future studies. 
Attributing function to these CSD effects on gene expression can only be done conservatively 
in the absence of evidence for corresponding effects at the protein level. One pathway via which 
increased central immune-inflammatory activity has been proposed to impact on brain function is 
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oxidative stress and neurotoxicity leading to inhibition of dopamine and serotonin function (Felger 
and Miller, 2012; Haroon et al., 2012; Miller et al., 2009). In this respect it is noteworthy that for 
AMYG, a number of the genes de-regulated by CSD express proteins that are either mediators or 
regulators of DA function: Drd2, Adora2a, Gpr88, Darpp-32, Rgs9, Slc29a4 and, as discussed above, 
Gng7 (as well as Prkcd in mPFC) (Table 1). Dopamine is released into the basolateral (BLA) and 
central (CeA) AMYG in the presence of emotional stimuli, and both regions express non-overlapping 
populations of D1 and D2 receptors, primarily on glutamate projection neurons in BLA and GABA 
neurons in CeA (Perez de la Mora et al., 2012). D2R expression is high in CeA, as it is in the inter-
connected structures of bed nucleus of stria terminalis and nucleus accumbens (central extended 
AMYG) and dorsal striatum-external pallidum (Alheid and Heimer, 1988). D2R antagonism, including 
in the CeA specifically, has been demonstrated to decrease two-way avoid-escape and increase fear 
(Perez de la Mora et al., 2010; Reis et al., 2004). The D2R interacts antagonistically with the 
adenosine receptor A2AR by forming heteromers (Boison et al., 2012); because expression of both 
Drd2 and Adora2a was decreased by CSD it is difficult to predict the functional consequences; 
nonetheless it is noteworthy that striatum-specific Adora2a knockout mice exhibited decreased 
activity and two-way avoid-escape (Singer et al., 2013), as observed in CSD mice. Both Adora2a and 
Gpr88 exhibit enriched expression in the central extended AMYG and dorsal striatum (Becker et al., 
2008); accordingly, the decreased expression observed in CSD mice might have occurred primarily in 
CeA indicating that future studies should analyse CSD effects on gene expression here and in striatal 
regions. In striatum, Gpr88 is expressed on GABA medium spiny neurons also expressing D2R or D1R; 
Gpr88 knockout mice exhibited impaired two-way avoid-escape (Quintana et al., 2012), as observed 
in CSD mice. Darpp-32 encodes a signalling phosphoprotein expressed in D2R and D1R neurons and 
is a major integrator of signals from neurotransmitters and neuromodulators targeting these 
neurons; again, it has been studied mainly in striatum but decreased expression here or in AMYG 
would be predicted to have important consequences for DA neuron function and behaviour (Bateup 
et al., 2010). Rgs9 encodes a protein, Rgs9-2, that modulates D2R function: Rgs9 knockout mice 
exhibited increased locomotor activation in response to amphetamine, indicating that Rgs9-2 
normally reduces D2R signalling (Rahman et al., 2003); however, in such mice there was no change 
in D2R levels, whereas in CSD mice the decrease in Rgs9 might constitute a response to decreased 
D2R levels. Slc29a4 encodes a presynaptic protein expressed by monoamine neurons, including in 
AMYG, and catalyses monoamine reuptake (Dahlin et al., 2007); Slc29a4 was up-regulated in the 
AMYG of CSD mice, suggesting that their DA and 5-HT reuptake might be increased. Finally, the 
current finding that CSD decreases Drd2 expression is also significant in the light of the evidence that 
striatal D2R is a positive modulator of motivation (Trifilieff et al., 2013), DA-striatal dysfunction 
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underlies fatigue (Capuron et al., 2007; Demyttenaere et al., 2005), and a polymorphism in D2R 
associated with reduced D2R density, particularly in dorsal striatum, is associated with increased risk 
of depression (Zou et al., 2012). 
Overall, the present experiments demonstrate that chronic social defeat in adult male 
C57BL/6 mice leads to altered processing of aversive physical stimuli in the form of increased 
emotional fear, decreased motivation to respond actively to the aversive stimulus, decreased 
response-control cognitive expectancy, and increased fatigability. These effects are relevant to 
specific psychopathology symptoms and features in depression and also to the generalized 
helplessness theory of depression onset-maintenance. The model therefore has aetiological and face 
validity and can be utilised to investigate the specific processes mediating between chronic social 
defeat and these depression-relevant behavioural effects. In this respect, evidence is presented for 
potentially important roles of immune-inflammation and altered dopamine function, and these two 
processes could be causally linked. Future studies will investigate these hypotheses, with a view to 
applying the model to identify novel targets for treatment of specific psychopathologies such as 
generalized helplessness or fatigue, and to conduct preclinical screening of compounds/biologics 
developed to act at these targets.     
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Figure Captions 
Figure 1. Experimental designs. Three experiments were conducted with mice exposed to chronic 
social defeat (CSD) or control handling (CON) on days 1-15. Mice were handled prior to experiments 
and body weights were measured daily. Experiment A: a 3-day test paradigm of motor activity (MA), 
contextual fear acquisition (FA) and two-way escape-avoidance (E-A) was conducted on days 16, 17 
and 18, respectively. Morning faecal boli (FB) were collected on days 17-19 in the waste tray of the 
behavioural test apparatus for corticosterone (CORT) metabolite determination. A hot plate test (HP) 
was conducted on day 19, and mice were killed (K) and physiological samples were collected on day 
20, including blood samples for cytokine and CORT determinations. Experiment B: Treadmill training 
(TTr) and a treadmill pre-test and test (TTe) were conducted on days 18 and 19, respectively, and a 
second TTe was conducted on day 29. The 3-day MA, FA, E-A paradigm was conducted on days 30-
32, and HP on day 33. Mice were killed and physiological samples were collected on day 34. 
Experiment C: Mice were killed on day 17 and brains were collected for genome-wide gene 
expression in ventral hippocampus, amygdala, and medial prefrontal cortex using next generation 
sequencing (NGS). 
 
Figure 2. Experiment A, effects of 15-day chronic social defeat mice (CSD, N = 13) versus control 
(CON, N = 12) in tests of motor activity, fear acquisition and two-way avoid-escape on days 16, 17 
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and 18, respectively. (A) Percent time freezing in the motor activity test (MA) and mean percent 
time freezing during 14 inter-trial intervals in the fear acquisition test (FA). (B) Mean reactivity 
(distance moved) to 15 inescapable electroshocks in the FA test. (C)-(F) Two-way avoid-escape test 
with 30 tone-escapable electroshock  trials: (C) Mean latency to avoid-escape response, (D) Total 
avoid responses, (E) Mean percent time freezing during tones and ITIs, (F) Mean reactivity to 
escapable electroshocks. P values are for Student’s t-test. 
 
Figure 3. Experiment B, effects of 15-day chronic social defeat mice (CSD, N = 11-13) versus control 
(CON, N = 10) in the treadmill fatigue test. (A) Day 19, total duration of electroshock received during 
5-min pre-test at treadmill speed of 20 cm/sec on. The 2 CSD mice that received 60 sec of 
electroshock were removed from the experiment for welfare reasons. (B) Day 19, running time 
achieved during 20-min (maximum) test at treadmill speed of 25 cm/sec. (C) Day 29, total duration 
of electroshock received during 5-min pre-test at treadmill speed of 20 cm/sec. (D) Day 29, running 
time achieved during 20-min (maximum) test at treadmill speed of 25 cm/sec. P values are for 
Student’s t-test. Mice that received less than 10 sec electroshocks during tests were exposed to a 
further short session at high speed (35 cm/sec) until their total electroshock exposure reached 10 
sec, so that all mice received the same amount of electroshock prior to further behavioural testing. 
 
Figure 4. Experiment B, effects of 15-day chronic social defeat mice (CSD, N = 11-13) versus control 
(CON, N = 10) in tests of motor activity, fear acquisition and two-way avoid-escape on day 30, 31 and 
32, respectively. (A) Percent time freezing in the motor activity test (MA) and mean percent time 
freezing during 14 inter-trial intervals in the fear acquisition test (FA). (B) Mean reactivity (distance 
moved) to 15 inescapable electroshocks in the FA test. (C)-(F) Two-way avoid-escape test with 30 
tone-escapable electroshock  trials: (C) Mean latency to avoid-escape response, (D) Total avoid-
escape failures, (E) Mean percent time freezing during tones and ITIs, (F) Mean reactivity to 
escapable electroshocks. P values are for Student’s t-test. 
 
Figure 5. Experiment A, Effects of 15-day chronic social defeat mice (CSD, N = 13) versus control 
(CON, N = 12) on body weight, inflammation markers and adrenal gland-corticosterone (CORT) 
markers. (A) Mean absolute body weight  at 14:00 h in 5-day blocks (overall mean +/- SD). (B) Mean 
percent day-to-day body weight delta (abs(BW day n – BW day n-1))/(BW day n-1)*100) (overall 
mean +/- SD) * p < 0.05 for CSD versus CON mice in day block indicated, using Group x Day block 
ANOVA and post hoc tests per Day-block. End-point measures on day 20: (C) Basal plasma tumor 
necrosis factor (TNF). P value is for Student’s t-test. (D) Basal plasma interleukin-6 (IL-6). P value is 
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for Mann-Whitney U-test. (E) Spleen weight relative to body weight. P value is for Student’s t-test. 
(F) Total adrenal gland weight relative to body weight. P value are for Student’s t-test. (G) Basal 
plasma corticosterone (CORT). (H) Faecal CORT metabolite (mean +/- SD) on day after motor activity 
test (day 17), fear acquisition test (day 18) and two-way avoid-escape test (day 19). a vs. b, p < 0.05 
in CON mice specifically, using Group x Day block ANOVA and a posteriori group-specific ANOVAs. 
 
Figure 6. Experiment C, investigation into effects of 15-day chronic social defeat on region-specific 
gene expression at day 17, using next generation sequencing with mRNA obtained from CSD mice (N 
= 12) and CON mice (N = 12). No pooling of samples was conducted i.e. for CSD and CON groups, 12 
replicates were run. (A) Venn-diagram of genes that exhibited significantly decreased (↓) or 
increased (↑) expression in CSD relative to CON mice in one or more of ventral hippocampus, 
amygdala and medial prefrontal cortex. Criteria used to identify differential gene expression in CSD 
relative to CON mice were mean reads per kilo base per million (RPKM) > 5, mean fold change > 1.4, 
and q < 0.05.The three canonical pathways most enriched by these differentially-expressed genes, as 
identified using Ingenuity Pathway Analysis, are given for amygdala and medial prefrontal cortex. 
(B)-(D) Representative figures (from (Franklin and Paxinos, 2008)) depicting the target region for (B) 
ventral hippocampus, (C) amygdala and (D) medial prefrontal cortex. For the complete listing of CSD-
induced altered gene expression, see supplementary tables S1 and S2. 
 
 
